Britschgi C - Search Results

1

ROS1 genomic rearrangements are rare actionable drivers in microsatellite stable colorectal cancer.

Akhoundova D, Hussung S, Sivakumar S, Töpfer A, Rechsteiner M, Kahraman A, Arnold F, Angst F, Britschgi C, Zoche M, Moch H, Weber A, Sokol E, Fritsch RM. Akhoundova D, et al. Among authors: britschgi c. Int J Cancer. 2022 Dec 15;151(12):2161-2171. doi: 10.1002/ijc.34257. Epub 2022 Aug 30. Int J Cancer. 2022. PMID: 36053834 Free PMC article.

2

Real-World Treatment Patterns and Survival Outcome in Advanced Anaplastic Lymphoma Kinase (ALK) Rearranged Non-Small-Cell Lung Cancer Patients.

Britschgi C, Addeo A, Rechsteiner M, Delaloye R, Früh M, Metro G, Banini M, Gautschi O, Rothschild SI, Wild PJ, Banna GL, Curioni-Fontecedro A. Britschgi C, et al. Front Oncol. 2020 Aug 21;10:1299. doi: 10.3389/fonc.2020.01299. eCollection 2020. Front Oncol. 2020. PMID: 32974130 Free PMC article.

3

The Role of the Liquid Biopsy in Decision-Making for Patients with Non-Small Cell Lung Cancer.

Akhoundova D, Mosquera Martinez J, Musmann LE, Britschgi C, Rütsche C, Rechsteiner M, Nadal E, Garcia Campelo MR, Curioni-Fontecedro A. Akhoundova D, et al. Among authors: britschgi c. J Clin Med. 2020 Nov 16;9(11):3674. doi: 10.3390/jcm9113674. J Clin Med. 2020. PMID: 33207619 Free PMC article. Review.

4

Setting a diagnostic benchmark for tumor BRCA testing: detection of BRCA1 and BRCA2 large genomic rearrangements in FFPE tissue - A pilot study.

Valtcheva N, Nguyen-Sträuli BD, Wagner U, Freiberger SN, Varga Z, Britschgi C, Dedes KJ, Rechsteiner MP. Valtcheva N, et al. Among authors: britschgi c. Exp Mol Pathol. 2021 Dec;123:104705. doi: 10.1016/j.yexmp.2021.104705. Epub 2021 Oct 9. Exp Mol Pathol. 2021. PMID: 34637782 Free article.

5

Targeting Secondary and Tertiary Resistance to BRAF Inhibition in BRAF V600E-Mutated Metastatic Colorectal Cancer.

Akhoundova D, Pietge H, Hussung S, Kiessling M, Britschgi C, Zoche M, Rechsteiner M, Weber A, Fritsch RM. Akhoundova D, et al. Among authors: britschgi c. JCO Precis Oncol. 2021 Nov;5:1082-1087. doi: 10.1200/PO.21.00107. JCO Precis Oncol. 2021. PMID: 34994629 Free article. No abstract available.

6

Comprehensive Statistical Exploration of Prognostic (Bio-)Markers for Responses to Immune Checkpoint Inhibitor in Patients with Non-Small Cell Lung Cancer.

Hiltbrunner S, Spohn ML, Wechsler R, Akhoundova D, Bankel L, Kasser S, Bihr S, Britschgi C, Maathuis MH, Curioni-Fontecedro A. Hiltbrunner S, et al. Among authors: britschgi c. Cancers (Basel). 2021 Dec 24;14(1):75. doi: 10.3390/cancers14010075. Cancers (Basel). 2021. PMID: 35008239 Free PMC article.

7

Molecular and immunophenotypic characterization of SMARCB1 (INI1) - deficient intrathoracic Neoplasms.

Haberecker M, Bühler MM, Mendieta AP, Guggenberger R, Arnold F, Markert E, Rechsteiner M, Zoche M, Britschgi C, Pauli C. Haberecker M, et al. Among authors: britschgi c. Mod Pathol. 2022 Dec;35(12):1860-1869. doi: 10.1038/s41379-022-01133-4. Epub 2022 Jul 21. Mod Pathol. 2022. PMID: 35864317 Free PMC article.

8

MTPpilot: An Interactive Software for Visualization of Next-Generation Sequencing Results in Molecular Tumor Boards.

Kahraman A, Arnold FM, Hanimann J, Nowak M, Pauli C, Britschgi C, Moch H, Zoche M. Kahraman A, et al. Among authors: britschgi c. JCO Clin Cancer Inform. 2022 Aug;6:e2200032. doi: 10.1200/CCI.22.00032. JCO Clin Cancer Inform. 2022. PMID: 36007219 Free PMC article.

9

Alectinib for the treatment of pretreated RET-rearranged advanced NSCLC: Results of the ETOP ALERT-lung trial.

Felip E, Smit EF, Molina-Vila MA, Dafni U, Massuti B, Berghmans T, de Marinis F, Passiglia F, Dingemans AC, Cobo M, Viteri S, Britschgi C, Cuffe S, Provencio M, Merkelbach-Bruse S, Andriakopoulou C, Kammler R, Ruepp B, Roschitzki-Voser H, Peters S, Wolf J, Stahel R; ETOP 12-17 ALERT-lung Collaborators. Felip E, et al. Among authors: britschgi c. Lung Cancer. 2022 Oct;172:94-99. doi: 10.1016/j.lungcan.2022.08.008. Epub 2022 Aug 12. Lung Cancer. 2022. PMID: 36030612 Free article. Clinical Trial.

10

Mutational Landscape and Expression of PD-L1 in Patients with Non-Small Cell Lung Cancer Harboring Genomic Alterations of the MET gene.

Fischer A, Bankel L, Hiltbrunner S, Rechsteiner M, Rüschoff JH, Rushing EJ, Britschgi C, Curioni-Fontecedro A. Fischer A, et al. Among authors: britschgi c. Target Oncol. 2022 Nov;17(6):683-694. doi: 10.1007/s11523-022-00918-6. Epub 2022 Sep 22. Target Oncol. 2022. PMID: 36136211 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

57 results

Search Page

Filters